Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 02 Oct 2024

M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication

in Vaccines and Molecular Therapeutics

Yibo Tang
Kaiming Tang
Yunqi Hu
Zi-Wei Ye
Wanyu Luo
Cuiting Luo
Hehe Cao
Ran Wang
Xinyu Yue
Dejian Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450114

4,056 views
1 citation

Correction

Published on 02 Oct 2024

Corrigendum: MAVS disruption impairs downstream signaling and results in higher virus replication levels of salmonid alphavirus subtype 3 but not infectious pancreatic necrosis virus in vitro

in Vaccines and Molecular Therapeutics

Cheng Xu
Amr A. A. Gamil
Xiaolin Wang
Hetron Mweemba Munang’andu
Øystein Evensen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500204

2,285 views

Original Research

Published on 01 Oct 2024

Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapy

in Vaccines and Molecular Therapeutics

Colton Ladbury
Claire Hao
William Tyler Watkins
Sagus Sampath
Jeffrey Wong
Arya Amini
Karen Sokolov
Jekwon Yeh
Karine A. Al Feghali
Dorine de Jong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419788

2,060 views
2 citations

Review

Published on 01 Oct 2024

Future applications of host direct therapies for infectious disease treatment

in Vaccines and Molecular Therapeutics

Ruth E. Thom
R V. D’Elia

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436557

3,906 views
11 citations

Original Research

Published on 01 Oct 2024

Nanospheres as the delivery vehicle: novel application of Toxoplasma gondii ribosomal protein S2 in PLGA and chitosan nanospheres against acute toxoplasmosis

in Vaccines and Molecular Therapeutics

WeiYu Qi
YouLi Yu
ChenChen Yang
XiaoJuan Wang
YuChen Jiang
Li Zhang
ZhengQing Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1475280

3,715 views

Review

Published on 30 Sep 2024

Integrating machine learning to advance epitope mapping

in Vaccines and Molecular Therapeutics

Simranjit Grewal
Nidhi Hegde
Stephanie K. Yanow

Frontiers in Immunology

doi 10.3389/fimmu.2024.1463931

5,708 views
6 citations

Correction

Published on 25 Sep 2024

Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

in Vaccines and Molecular Therapeutics

Shi Zou
Wei Guo
Songjie Wu
Fangzhao Ming
Yuting Tan
Mengmeng Wu
Weiming Tang
Ke Liang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494940

875 views

Original Research

Published on 24 Sep 2024

Characterisation and Immunogenicity of Neisseria cinerea outer membrane vesicles displaying NadA, NHBA and fHbp from Neisseria meningitidis serogroup B

in Vaccines and Molecular Therapeutics

Shathviga Manoharan
Theo A. Farman
Stavroula Piliou
Pietro Mastroeni

Frontiers in Immunology

doi 10.3389/fimmu.2024.1473064

2,527 views
1 citation

Original Research

Published on 24 Sep 2024

Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity

in Vaccines and Molecular Therapeutics

Chitra Upadhyay
Priyanka Rao
Mohammad Amin Behzadi
Roya Feyznezhad
Gregory S. Lambert
Rajnish Kumar
Madhu Kumar
Weiming Yang
Xunqing Jiang
Christina C. Luo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476924

2,538 views
4 citations

Original Research

Published on 17 Sep 2024

Tonsil explants as a human in vitro model to study vaccine responses

in Vaccines and Molecular Therapeutics

Elena Bonaiti
Manuele G. Muraro
Philippe A. Robert
Jens Jakscha
Stefan Dirnhofer
Ivan Martin
Christoph T. Berger

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425455

3,917 views
2 citations

Original Research

Published on 16 Sep 2024

Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium

in Vaccines and Molecular Therapeutics

Kohei Togami
Whitney Wolf
Lucas C. Olson
Madison Card
Limei Shen
Alison Schaefer
Kenichi Okuda
Larry Zeitlin
Michael Pauly
Kevin Whaley

Frontiers in Immunology

doi 10.3389/fimmu.2024.1371156

3,287 views

Original Research

Published on 16 Sep 2024

Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against Echinococcus multilocularis infection

in Vaccines and Molecular Therapeutics

Yichen Fan
Yueyue He
Yujiao Li
Zhengwei Yin
Juan Shi
Tingting Tian
Kaiyu Shang
Huidong Shi
Fengbo Zhang
Hao Wen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425603

2,676 views

Original Research

Published on 13 Sep 2024

Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice

in Vaccines and Molecular Therapeutics

Gabriela M. Escalante
Ivana G. Reidel
Lorraine Z. Mutsvunguma
Simeon Cua
Brenda A. Tello
Esther Rodriguez
Mafalda A. Farelo
Cloe Zimmerman
Murali Muniraju
He Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445209

3,789 views
5 citations

Review

Published on 12 Sep 2024

Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector

in Vaccines and Molecular Therapeutics

Xinru Luo
Ruiying Liang
Lin Liang
Aoxing Tang
Shaohua Hou
Jiabo Ding
Zibin Li
Xinming Tang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445387

6,624 views
1 citation

Original Research

Published on 12 Sep 2024

Role of circulating T follicular helper subsets following Ty21a immunization and oral challenge with wild type S. Typhi in humans

in Vaccines and Molecular Therapeutics

Jayaum S. Booth
Rekha R. Rapaka
Monica A. McArthur
Stephanie Fresnay
Thomas C. Darton
Christoph J. Blohmke
Claire Jones
Claire S. Waddington
Myron M. Levine
Andrew J. Pollard

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384642

2,041 views
1 citation

Original Research

Published on 12 Sep 2024

Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19

in Vaccines and Molecular Therapeutics

Hui Zheng
Cuidan Li
Xiuyu Zheng
Hu-Dachuan Jiang
Yuqing Li
Aihua Yao
Xiaolong Li
Feiyu Wang
Wenqing Liu
Xiang Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1461419

2,077 views
1 citation